class action lawsuit

Pomerantz files class action lawsuit against Bath & Body Works for alleged securities violations following missed earnings and stock decline in 2025.

Vistagen faces class action lawsuit after Phase 3 trial failure for anxiety drug. Stock plunged 80%. Investors must act by March 16, 2026 deadline.

NuScale Power faces securities fraud lawsuit over alleged misrepresentations about its ENTRA1 Energy partnership. Stock fell 70% after November 2025 disclosures of $495M payment and $532M loss.

Law firm launches investigation into Enhabit's $13.80-per-share acquisition by Kinderhook, examining if deal terms are fair and proper procedures were followed.

Lakeland Industries faces securities lawsuit over acquisition disclosures, alleging material misrepresentations about Pacific Helmets and Jolly deals. Stock fell 39% after earnings miss.

Shareholders sue Zynex for allegedly inflating revenue through improper recognition practices, false insurance claims, and overbilling customers, causing material losses.

Four major companies face securities fraud lawsuits for misleading investors on AI spending, financial disclosures, and manufacturing claims. Investor filing deadlines approaching.

CoreWeave faces securities fraud lawsuit alleging false statements about operational capabilities and concealed business risks during 2025, following merger collapse and infrastructure delays.

Plug Power faces securities fraud lawsuit over alleged false statements about DOE loan program. Stock declined after executive departures and suspended loan activities.

Law firm investigates Alvotech after FDA rejected applications following failed facility inspection, causing stock to plunge 34%. Investors sought for potential securities litigation.

Navan faces securities fraud lawsuit over IPO disclosure gaps regarding undisclosed sales expenses and slowing revenue growth. Stock fell 48% since offering.

Class action investigations launched against Ramaco Resources and Beyond Meat for alleged securities violations. Investors face deadlines of March 31 and March 24, 2026, respectively, to petition as lead plaintiffs.

Class action lawsuit filed against Navan alleging IPO disclosure failures on sales and marketing costs. Stock fell 64% from $25 to $9.01 since offering.

Corcept Therapeutics faces class action lawsuit for allegedly misleading statements about relacorilant's clinical evidence. FDA rejected the drug application, causing stock to plummet 50%.

Ostin Technology faces class action lawsuit alleging securities fraud scheme involving fraudulent offerings and stock price manipulation that netted $110 million before collapsing 94%.

Masonite faces securities fraud lawsuit for allegedly hiding Owens Corning acquisition talks while repurchasing stock. Investors have until April 2026 to join class action.

Rosen Law Firm investigates Lufax for potential disclosure violations after auditor removal announcement triggered 13.8% stock decline. Class action lawsuit evaluation ongoing.

Navan faces class action lawsuit over alleged IPO disclosure failures regarding undisclosed marketing spending plans. Stock plunged 63% after December earnings announcement revealed 39% expense increase.

Bath & Body Works faces securities class action lawsuit alleging false statements about business strategy and growth projections. Investors have until March 13, 2026 to request lead plaintiff status.

Law firm Block & Leviton investigates Gemini Space Station stock collapse following three executive departures and 75% price decline from IPO, citing potential securities law violations.